EUVIMEDEUVIMED entdecken
Crossref

C4d May Predict Treatment Failure and Disease Progression in Primary Focal Segmental Glomerulosclerosis

Nikola Zagorec iD, Ivica Horvatić iD, Dino Kasumović iD, Besa Osmani, Slavica Sović, Matija Horaček iD, Petar Šenjug iD, Krešimir Galešić iD, Danica Galešić Ljubanović iD

Nephrology · 2026-11 · 31 (11)

DOI: 10.1111/nep.70306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology, online erschienen am 03.11.2026. Verfasst von Nikola Zagorec und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia. Hauptthemen laut MEDLINE: Glomerulosclerosis, Focal Segmental, Complement C4b, Kidney Glomerulus, Peptide Fragments. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the prognostic significance of C4d, a stable tissue marker of complement activation, in primary focal segmental glomerulosclerosis (pFSGS).

Methods

Immunohistochemistry for C4d was performed on paraffin‐embedded tissue in patients with pFSGS and only non‐globally sclerosed glomeruli were evaluated for C4d. Based on the ratio of C4d‐positive glomeruli/total number of glomeruli and number of C4d‐positive non‐sclerotic glomeruli and total number of non‐sclerotic glomeruli, patients were stratified into two subgroups: < 50% or ≥ 50% of C4d‐positive glomeruli. Association of C4d with disease progression (composite of kidney failure and > 50% reduction in baseline eGFR), renal survival and treatment failure was analysed.

Results

A total of 58 patients were included. Patients with ≥ 50% of C4d‐positive glomeruli had worse renal survival ( p = 0.005) and higher rate of treatment failure ( p = 0.002) and disease progression ( p = 0.025). Patients with ≥ 50% of C4d‐positive non‐sclerotic glomeruli had worse renal survival ( p = 0.034) and higher rate of treatment failure ( p = 0.009) and disease progression ( p = 0.046). C4d, either in all glomeruli (OR = 7.88, p = 0.013) or non‐sclerotic glomeruli (OR = 4.97, p = 0.021), was independently associated with treatment failure. C4d deposits in ≥ 50% of all glomeruli and nonsclerotic glomeruli only were independently associated with progression to composite outcome (HR = 5.89, p = 0.011) and (HR = 3.93, p = 0.031), respectively, together with percentage of interstitial fibrosis and tubular atrophy.

Conclusion

C4d seems to be independently associated with treatment failure and disease progression in pFSGS. Beyond the influence on risk stratification in pFSGS, this study may prompt trials with complement interfering agents in pFSGS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulosclerosis, Focal SegmentalComplement C4bKidney GlomerulusPeptide FragmentsHumansDisease ProgressionFemaleTreatment FailureMaleImmunohistochemistryBiomarkersRisk FactorsAdultMiddle AgedPredictive Value of TestsBiopsyImmunosuppressive AgentsGlomerular Filtration RateRetrospective StudiesTime FactorsComplement Activation

Stichwörter der Autor:innen

C4dcomplement systemimmunohistochemistryprimary focal segmental glomerulosclerosisprognostic factors

Substanzen

Complement C4bcomplement C4dBiomarkersPeptide FragmentsImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Nephrology and Dialysis, Dubrava University Hospital, Zagreb, Croatia.
  • School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Faculty of Pharmacy and Biochemistry, University of Zagreb, Zagreb, Croatia.
  • School of Public Health, "Andrija Štampar", Zagreb, Croatia.
  • Department of Pathology, School of Medicine, University of Zagreb, Zagreb, Croatia.
  • Division of Nephropathology and Electron Microscopy, Department of Pathology and Cytology, Dubrava University Hospital, Zagreb, Croatia.

ORCID-Profile: Nikola Zagorec, Ivica Horvatić, Dino Kasumović, Matija Horaček, Petar Šenjug, Krešimir Galešić, Danica Galešić Ljubanović

Zitieren

APA

Zagorec, N., Horvatić, I., Kasumović, D., Osmani, B., Sović, S., Horaček, M., Šenjug, P., Galešić, K., & Ljubanović, D. G. (2026). C4d May Predict Treatment Failure and Disease Progression in Primary Focal Segmental Glomerulosclerosis. Nephrology, 31(11). https://doi.org/10.1111/nep.70306

Vancouver

Zagorec N, Horvatić I, Kasumović D, Osmani B, Sović S, Horaček M, et al. C4d May Predict Treatment Failure and Disease Progression in Primary Focal Segmental Glomerulosclerosis. Nephrology. 2026;31(11). doi:10.1111/nep.70306

BibTeX
@article{Zagorec2026,
  author = {Zagorec, Nikola and Horvatić, Ivica and Kasumović, Dino and Osmani, Besa and Sović, Slavica and Horaček, Matija and Šenjug, Petar and Galešić, Krešimir and Ljubanović, Danica Galešić},
  title = {C4d May Predict Treatment Failure and Disease Progression in Primary Focal Segmental Glomerulosclerosis},
  journal = {Nephrology},
  year = {2026},
  volume = {31},
  number = {11},
  doi = {10.1111/nep.70306}
}
Kostenlos starten →